Characteristics and Long-Term Efficacy of 25 Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with Eculizumab or Ravulizumab in Taiwan

被引：0
作者：
Lin, Hsing-Yu [1 ]
Chen, Yu-Wen [1 ]
Yu, Ta-Chuan [2 ]
Tien, Feng-Ming [3 ,4 ]
Lin, Chien-Chin [4 ,5 ]
Chou, Sheng-Chieh [4 ]
Wu, Shang-Ju [4 ]
Ko, Bor-Sheng [4 ,6 ]
Yang, Yung-Li [7 ,8 ]
Yao, Ming [4 ]
Tsay, Woei [4 ]
Tien, Hwei-Fang [4 ,9 ]
Hou, Hsin-An [4 ]
Chou, Wen-Chien [4 ,5 ]
机构：
[1] Natl Taiwan Univ Hosp, Dept Pharm, Taipei, Taiwan
[2] Natl Taiwan Univ Hosp, Yunlin Branch, Dept Internal Med, Yunlin, Taiwan
[3] Natl Taiwan Univ, Grad Inst Clin Med, Coll Med, Taipei, Taiwan
[4] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan
[5] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan
[6] Natl Taiwan Univ, Canc Ctr, Dept Hematol Oncol, Taipei, Taiwan
[7] Natl Taiwan Univ, Canc Ctr, Dept Lab Med, Taipei, Taiwan
[8] Natl Taiwan Univ Hosp, Dept Pediat, Taipei, Taiwan
[9] Far Eastern Mem Hosp, Dept Internal Med, New Taipei, Taiwan
来源：
BLOOD | 2024年 / 144卷
关键词：
D O I：
10.1182/blood-2024-199918
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：5672 / 5673
页数：2
相关论文
共 50 条
  • [31] Outcome characteristics of patients with paroxysmal nocturnal hemoglobinuria (PNH): data from the German PNH registry including eculizumab, ravulizumab and untreated patients
    Roth, A.
    Alashkar, F.
    Panse, J.
    Sockel, K.
    Haferlach, T.
    Hubel, K.
    Blau, I. W.
    Platzbecker, U.
    Hochsmann, B.
    Schrezenmeier, H.
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 174 - 174
  • [32] Danicopan As Add-on Therapy to Ravulizumab or Eculizumab in Patients with Paroxysmal Nocturnal Hemoglobinuria: Long-Term Patient-Reported Outcomes from the Phase 3 ALPHA Trial
    Piatek, Caroline
    Lee, Jong Wook
    Griffin, Morag
    Nishimura, Jun-Ichi
    Patriquin, Christopher
    Schrezenmeier, Hubert
    Barcellini, Wilma
    Shammo, Jamile
    Gaya, Anna
    Mahdi, Mohammed
    Liu, Peng
    Myren, Karl-Johan
    Messali, Andrew
    de Fontbrune, Flore Sicre
    Panse, Jens
    Kulasekararaj, Austin G.
    BLOOD, 2024, 144 : 2693 - 2694
  • [33] Pharmacokinetics, pharmacodynamics, efficacy, and safety of ravulizumab in pediatric paroxysmal nocturnal hemoglobinuria
    Chonat, Satheesh
    Kulagin, Alexander
    Maschan, Alexey
    Bartels, Marije
    Buechner, Jochen
    Punzalan, Rowena
    Richards, Michael
    Ogawa, Masayo
    Hicks, Eden
    Yu, Ji
    Baruchel, Andre
    Kulasekararaj, Austin G.
    BLOOD ADVANCES, 2024, 8 (11) : 2813 - 2824
  • [34] Efficacy of iptacopan monotherapy for suboptimal response to eculizumab in patients with paroxysmal nocturnal hemoglobinuria
    Klimova, Olesya U.
    Golubovskaya, Irina K.
    Kuznetsov, Yuriy N.
    Marchenko, Maria, V
    Kulagin, Alexander D.
    TERAPEVTICHESKII ARKHIV, 2025, 97 (01) : 46 - 53
  • [35] EFFICACY OF THE COMPLEMENT INHIBITOR ECULIZUMAB IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA PATIENTS NEVER TRANSFUSED
    Risitano, A.
    Alfinito, F.
    Seneca, E.
    Marando, L.
    Boschetti, C.
    Bonfigli, S.
    Fenu, S.
    Re, F.
    Gosetti, G.
    Khursigara, G.
    Rother, R.
    Zanella, A.
    Rotoli, B.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 237 - 237
  • [36] Long-Term Safety and Efficacy of Pegcetacoplan Treatment in Adults with Paroxysmal Nocturnal Hemoglobinuria
    Patriquin, C. J.
    Bogdanovic, A.
    Griffin, M.
    Kelly, R.
    Maciejewski, J. P.
    Mulherin, B.
    De Latour, Peffault R.
    Roeth, A.
    Selvaratnam, V.
    Szer, J.
    Savage, J.
    Horneff, R.
    Tan, L.
    Yeh, M.
    Panse, J.
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 203 - 204
  • [37] EFFICACY AND SAFETY OF ECULIZUMAB IN CHILDREN AND ADOLESCENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA
    Reiss, U.
    Schwartz, J.
    Puthenveetil, G.
    Ogawa, M.
    Ware, R.
    HAEMATOLOGICA, 2012, 97 : 370 - 371
  • [38] Efficacy of Eculizumab in Pediatric Patients with Paroxysmal Nocturnal Hemoglobinuria in the International PNH Registry
    Urbano-Ispizua, Alvaro
    Kulasekararaj, Austin G.
    Bartels, Marije
    Patriquin, Christopher J.
    Hoechsmann, Britta
    Maschan, Alexey A.
    Wilson, Amanda
    Gustovic, Philippe
    Schrezenmeier, Hubert
    BLOOD, 2018, 132
  • [39] Comparative effectiveness of pegcetacoplan versus ravulizumab in patients with paroxysmal nocturnal hemoglobinuria previously treated with eculizumab: a matching-adjusted indirect comparison
    Bhak, Rachel
    Mody-Patel, Nikita
    Baver, Scott B.
    Kunzweiler, Colin
    Yee, Christopher
    Sundaresan, Sanjana
    Swartz, Natalia
    Duh, Mei Sheng
    Krishnan, Sangeeta
    Sarda, Sujata P.
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 : 190 - 190
  • [40] Real-World Clinical Outcomes in Patients With Paroxysmal Nocturnal Hemoglobinuria Treated With Eculizumab or Ravulizumab in the US: A Retrospective Claims Database Analysis
    Tantravahi, Srinivas
    Latremouille-Viau, Dominick
    Desai, Raj
    Lee, Soyon
    Paulose, Jincy
    Geevarghese, Anumaxine
    Guerin, Anne
    Seshasayee, Shravanthi
    Chanpura, Mohin
    Yen, Glorian
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S599 - S599
12345